These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30032875)

  • 21. Implications of the use of neuromuscular transmission monitoring on immediate postoperative extubation in off-pump coronary artery bypass surgery.
    Cammu G; De Keersmaecker K; Casselman F; Coddens J; Hendrickx J; Van Praet E; Deloof T
    Eur J Anaesthesiol; 2003 Nov; 20(11):884-90. PubMed ID: 14649340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
    Gaszynski T; Szewczyk T; Gaszynski W
    Br J Anaesth; 2012 Feb; 108(2):236-9. PubMed ID: 22012861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuromuscular and Clinical Recovery in Thoracic Surgical Patients Reversed With Neostigmine or Sugammadex.
    Murphy GS; Avram MJ; Greenberg SB; Bilimoria S; Benson J; Maher CE; Teister KJ; Szokol JW
    Anesth Analg; 2021 Aug; 133(2):435-444. PubMed ID: 33323787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study.
    Sasaki N; Meyer MJ; Malviya SA; Stanislaus AB; MacDonald T; Doran ME; Igumenshcheva A; Hoang AH; Eikermann M
    Anesthesiology; 2014 Nov; 121(5):959-68. PubMed ID: 25225821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sugammadex Versus Neostigmine for Neuromuscular Block Reversal and Postoperative Pulmonary Complications in Patients Undergoing Resection of Lung Cancer.
    Yu Y; Wang H; Bao Q; Zhang T; Chen B; Ding J
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3626-3633. PubMed ID: 35662514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sugammadex antagonism of rocuronium-induced neuromuscular blockade in patients with liver cirrhosis undergoing liver resection: a randomized controlled study.
    Abdulatif M; Lotfy M; Mousa M; Afifi MH; Yassen K
    Minerva Anestesiol; 2018 Aug; 84(8):929-937. PubMed ID: 29405667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery of early postoperative muscle strength after deep neuromuscular block by means of ultrasonography with comparison of neostigmine versus sugammadex as reversal drugs: study protocol for a randomised controlled trial.
    Wang X; Li Y; Huang C; Xiong W; Zhou Q; Niu L; Xiao Y
    BMJ Open; 2021 Feb; 11(2):e043935. PubMed ID: 33637547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada.
    Insinga RP; Joyal C; Goyette A; Galarneau A
    BMC Anesthesiol; 2016 Nov; 16(1):114. PubMed ID: 27852231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.
    de Boer HD; Carlos RV; Brull SJ
    BMC Anesthesiol; 2018 Nov; 18(1):159. PubMed ID: 30400850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of calcium chloride coadministered with neostigmine on neuromuscular blockade recovery: A double-blind randomised study.
    Ju JW; Kim HC; Yoon S; Hong DM; Park HP
    Eur J Anaesthesiol; 2017 Sep; 34(9):617-622. PubMed ID: 28763316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial.
    Sauer M; Stahn A; Soltesz S; Noeldge-Schomburg G; Mencke T
    Eur J Anaesthesiol; 2011 Dec; 28(12):842-8. PubMed ID: 21455074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observational study on patterns of neuromuscular blockade reversal.
    Dubovoy T; Housey M; Devine S; Kheterpal S
    BMC Anesthesiol; 2016 Oct; 16(1):103. PubMed ID: 27770778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for administration of additional reversal following neuromuscular blockade with rocuronium in children: A retrospective case-control study.
    Vishneski SR; Saha AK; Fram MR; Templeton LB; Lee LK; Ririe DG; Goenaga-Diaz EJ; Smith LD; Templeton TW
    Paediatr Anaesth; 2022 Aug; 32(8):916-925. PubMed ID: 35438816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of neostigmine and sugammadex on postoperative residual curarization and postoperative pulmonary complications by means of diaphragm and lung ultrasonography: a study protocol for prospective double-blind randomized controlled trial.
    Zhang YG; Chen Y; Zhang YL; Yi J
    Trials; 2022 May; 23(1):376. PubMed ID: 35526047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of residual paralysis after a single intubating dose of rocuronium on postoperative pulmonary function of patients undergoing laparoscopic gynecological surgeries].
    Bai YH; Ren HZ; Luo AL; Huang YG; Ye TH; Guo XY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):102-7. PubMed ID: 20236598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermediate-Acting Nondepolarizing Neuromuscular Blocking Agents and Risk of Postoperative 30-Day Morbidity and Mortality, and Long-term Survival.
    Bronsert MR; Henderson WG; Monk TG; Richman JS; Nguyen JD; Sum-Ping JT; Mangione MP; Higley B; Hammermeister KE
    Anesth Analg; 2017 May; 124(5):1476-1483. PubMed ID: 28244947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.
    Schepens T; Cammu G; Saldien V; De Neve N; Jorens PG; Foubert L; Vercauteren M
    Eur J Anaesthesiol; 2015 Jan; 32(1):49-57. PubMed ID: 25111539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.